C07D 213/56
Amides
C07D213/56 (Amides) appears on 1,001 US grants and 1,013 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,001
- Published applications
- 1,013
- Assignees
- 559
- Inventors
- 3,714
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 3 | 0 |
| 1978 | 3 | 0 |
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 2 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 7 | 0 |
| 1986 | 6 | 0 |
| 1987 | 4 | 0 |
| 1988 | 9 | 0 |
| 1989 | 5 | 0 |
| 1990 | 7 | 0 |
| 1991 | 5 | 0 |
| 1992 | 14 | 0 |
| 1993 | 15 | 0 |
| 1994 | 18 | 0 |
| 1995 | 16 | 0 |
| 1996 | 24 | 0 |
| 1997 | 30 | 0 |
| 1998 | 21 | 0 |
| 1999 | 22 | 0 |
| 2000 | 23 | 0 |
| 2001 | 25 | 1 |
| 2002 | 37 | 40 |
| 2003 | 20 | 30 |
| 2004 | 22 | 48 |
| 2005 | 15 | 30 |
| 2006 | 21 | 31 |
| 2007 | 19 | 38 |
| 2008 | 23 | 36 |
| 2009 | 24 | 55 |
| 2010 | 17 | 52 |
| 2011 | 36 | 41 |
| 2012 | 33 | 37 |
| 2013 | 38 | 39 |
| 2014 | 47 | 63 |
| 2015 | 42 | 48 |
| 2016 | 48 | 65 |
| 2017 | 63 | 41 |
| 2018 | 31 | 45 |
| 2019 | 34 | 45 |
| 2020 | 27 | 45 |
| 2021 | 31 | 35 |
| 2022 | 23 | 29 |
| 2023 | 21 | 38 |
| 2024 | 24 | 35 |
| 2025 | 27 | 31 |
| 2026 | 15 | 15 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- Reagent for mass spectrometry29 Sep 2026US 12,748,116 B2Roche Diagnostics Operations, Inc.
- Cancer combination therapies utilizing a nicotinamide phosphoribosyltransferase inhibitor in combination with a nicotinamide adenine dinucleotide salvage pathway precursor25 Aug 2026US 12,714,722 B2Fred Hutchinson Cancer Center
- Chemical compounds and uses thereof23 Jun 2026US 12,662,451 B2Glaxosmithkline Intellectual Property (No. 4) Ltd.
- USP30 inhibitors and uses thereof2 Jun 2026US 12,643,852 B2Vincere Biosciences, Inc.
- Novel carboxamide derivatives8 Oct 2026US 2026/0308149 A1Angelini Pharma S.P.A.
- Novel mitofusin inhibitors17 Sep 2026US 2026/0274810 A1Albert Einstein College of Medicine
- At2 antagonists for non-addictive pain relief20 Aug 2026US 2026/0242357 A1Board of Regents, The University of Texas System
- Solid state forms of resmetirom13 Aug 2026US 2026/0232680 A1Assia Chemical Industries Ltd.
- Amide compounds or salts thereof, bactericidal agents for agriculture and horticulture containing said compounds, and method of using same23 Jul 2026US 2026/0206763 A1Nihon Nohyaku Co., Ltd.
Most cited
By later US patents
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Glutaramide diuretic agents156US 5,030,654 APfizer Inc. · 1991
- Substituted pyridyl-dihydroxy-heptenoic acid and its salts148US 5,177,080 ABayer Aktiengesellschaft · 1993
- Cell differentiation inducer110US 6,174,905 B1Mitsui Chemicals, Inc. · 2001
- Novel, transient pro-drug forms of L-DOPA to treat Parkinson's disease109US 4,035,507 AINTERx Research Corporation · 1977